Strides Pharma Asia has agreed to purchase a 55% stake in South African pharmaceutical company Trinity Pharma for R55m ($4.31m).
Following the acquisition, Trinity Pharma’s management will continue as minority partner, running the business under the supervision of Strides Pharma Asia.
Strides Pharma Asia is a Singaporean pharmaceutical company and a subsidiary of Strides Shasun. The acquisition will enable the company to establish its presence in South Africa.
GlaxoSmithKline (GSK) has purchased an additional 26% stake in Glaxo Saudi Arabia (GSAL) increasing its total stake to 75%.
The acquisition will enable the UK-based pharmaceutical company to expand its presence in Saudi Arabia.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData